Alberini CM, Cruz E, Descalzi G, Bessières B, Gao V (2018) Astrocyte glycogen and lactate: new insights into learning and memory mechanisms. Glia 66(6):1244–1262. https://doi.org/10.1002/glia.23250
Google Scholar
Andersen JV, Markussen KH, Jakobsen E, Schousboe A, Waagepetersen HS, Rosenberg PA, Aldana BI (2021) Glutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration. Neuropharmacology 196:108719. https://doi.org/10.1016/j.neuropharm.2021.108719
Google Scholar
Asai H, Ikezu S, Tsunoda S, Medalla M, Luebke J, Haydar T, Wolozin B, Butovsky O, Kügler S, Ikezu T (2015) Depletion of microglia and inhibition of exosome synthesis halt Tau propagation. Nat Neurosci 18(11):1584–1593. https://doi.org/10.1038/nn.4132
Google Scholar
Baker LD, Pa JA, Katula JA, Aslanyan V, Salmon DP, Jacobs DM, Chmelo EA, Hodge H, Morrison R, Matthews G, Brewer J, Jung Y, Rissman RA, Taylor C, Léger GC, Messer K, Evans AC, Okonkwo OC, Shadyab AH, Zou J, Jin S, Thomas RG, Zhang J, La Croix AZ, Cotman CW, Feldman HH (2025) Effects of exercise on cognition and Alzheimer’s biomarkers in a randomized controlled trial of adults with mild cognitive impairment: the EXERT study. Alzheimers Dement 21(4):e14586. https://doi.org/10.1002/alz.14586
Google Scholar
Banks WA, Gray AM, Erickson MA, Salameh TS, Damodarasamy M, Sheibani N, Meabon JS, Wing EE, Morofuji Y, Cook DG, Reed MJ (2015) Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit. J Neuroinflammation 12(1):223. https://doi.org/10.1186/s12974-015-0434-1
Google Scholar
Barloese MCJ, Bauer C, Petersen ET, Hansen CS, Madsbad S, Siebner HR (2022) Neurovascular coupling in type 2 diabetes with cognitive decline. A narrative review of neuroimaging findings and their pathophysiological implications. Front Endocrinol (Lausanne) 13:874007. https://doi.org/10.3389/fendo.2022.874007
Google Scholar
Belaidi AA, Bush AI, Ayton S (2025a) Apolipoprotein E in Alzheimer’s disease: molecular insights and therapeutic opportunities. Mol Neurodegener 20(1):47. https://doi.org/10.1186/s13024-025-00843-y
Google Scholar
Belaidi AA, Bush AI, Ayton S (2025b) Apolipoprotein E in Alzheimer’s disease: molecular insights and therapeutic opportunities. Mol Neurodegener 20(1):47. https://doi.org/10.1186/s13024-025-00843-y
Google Scholar
Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, Wu Z, Holtzman DM, Betsholtz C, Armulik A, Sallstrom J, Berk BC, Zlokovic BV (2012) Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature 485(7399):512–516. https://doi.org/10.1038/nature11087
Google Scholar
Benzinger TLS, Blazey T, Jack CR, Koeppe RA, Su Y, Xiong C, Raichle ME, Snyder AZ, Ances BM, Bateman RJ, Cairns NJ, Fagan AM, Goate A, Marcus DS, Aisen PS, Christensen JJ, Ercole L, Hornbeck RC, Farrar AM, Aldea P, Jasielec MS, Owen CJ, Xie X, Mayeux R, Brickman A, McDade E, Klunk W, Mathis CA, Ringman J, Thompson PM, Ghetti B, Saykin AJ, Sperling RA, Johnson KA, Salloway S, Correia S, Schofield PR, Masters CL, Rowe C, Villemagne VL, Martins R, Ourselin S, Rossor MN, Fox NC, Cash DM, Weiner MW, Holtzman DM, Buckles VD, Moulder K, Morris JC (2013) Regional variability of imaging biomarkers in autosomal dominant Alzheimer’s disease. Proc Natl Acad Sci 110(47):E4502–E4509. https://doi.org/10.1073/pnas.1317918110
Google Scholar
Bernetti C, D’Andrea V, Buoso A, Barbalace I, Greco F, Pilato F, Calandrelli R, Di Lazzaro V, Zobel BB, Mallio CA (2025) Arterial spin labeling MRI in Alzheimer’s disease: a systematic review of cerebral perfusion biomarkers. J Neuroimaging 35(2):e70035. https://doi.org/10.1111/jon.70035
Google Scholar
Biessels GJ, Despa F (2018) Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol 14(10):591–604. https://doi.org/10.1038/s41574-018-0048-7
Google Scholar
Bracher-Smith M, Melograna F, Ulm B, Bellenguez C, Grenier-Boley B, Duroux D, Nevado AJ, Holmans P, Tijms BM, Hulsman M, de Rojas I, Campos-Martin R, der Lee Sv, Castillo A, Küçükali F, Peters O, Schneider A, Dichgans M, Rujescu D, Scherbaum N, Deckert J, Riedel-Heller S, Hausner L, Molina-Porcel L, Düzel E, Grimmer T, Wiltfang J, Heilmann-Heimbach S, Moebus S, Tegos T, Scarmeas N, Dols-Icardo O, Moreno F, Pérez-Tur J, Bullido MJ, Pastor P, Sánchez-Valle R, Álvarez V, Boada M, García-González P, Puerta R, Mir P, Real LM, Piñol-Ripoll G, García-Alberca JM, Rodriguez-Rodriguez E, Soininen H, Heikkinen S, de Mendonça A, Mehrabian S, Traykov L, Hort J, Vyhnalek M, Sandau N, Thomassen JQ, Pijnenburg YAL, Holstege H, van Swieten J, Ramakers I, Verhey F, Scheltens P, Graff C, Papenberg G, Giedraitis V, Williams J, Amouyel P, Boland A, Deleuze J-F, Nicolas G, Dufouil C, Pasquier F, Hanon O, Debette S, Grünblatt E, Popp J, Ghidoni R, Galimberti D, Arosio B, Mecocci P, Solfrizzi V, Parnetti L, Squassina A, Tremolizzo L, Borroni B, Wagner M, Nacmias B, Spallazzi M, Seripa D, Rainero I, Daniele A, Piras F, Masullo C, Rossi G, Jessen F, Kehoe P, Magda T, Sánchez-Juan P, Sleegers K, Ingelsson M, Hiltunen M, Sims R, van der Flier W, Andreassen OA, Ruiz A, Ramirez A, Jansen I, van der Lee S, Andrade V, Fernández V, Dalmasso M-C, Kleineidam L, Ahmad S, Aarsland D, Cano A, Abdelnour C, Alarcón-Martín E, Alcolea D, Alegret M, Alvarez I, Armstrong NJ, Anthoula T, Appollonio I, Arcaro M, Archetti S, Pastor AA, Athanasiu L, Bailly H, Banaj N, Baquero M, Pastor AB, Berr C, Besse C, Bessi V, Binetti G, Fostinelli S, Bellini S, Bizarro A, Blesa R, Boada M, Boschi S, Bossù P, Bråthen G, Bresner C, Brodaty H, Brookes KJ, Buiza-Rueda D, Bûrger K, Burholt V, Calero M, Chene G, Carracedo Á, Cecchetti R, Cervera-Carles L, Charbonnier C, Chillotti C, Ciccone S, Claassen JAHR, Clarimon J, Clark C, Conti E, Corma-Gómez A, Giuffrè GM, Custodero C, Daian D, Dardiotis E, Dartigues J-F, de Deyn PP, del Ser T, Denning N, Diehl-Schmid J, Diez-Fairen M, Rossi PD, Djurovic S, Duron E, Engelborghs S, Blázquez J, Ewers M, Fabrizio T, Nielsen SF, Farotti L, Fenoglio C, Fernández-Fuertes M, Ferreira CB, Ferri E, Fin B, Fischer P, Fladby T, Fließbach K, Fortea J, Foroud TM, Fostinelli S, Fox NC, Franco-Macías E, Frank-García A, Froelich L, García-Alberca JM, García-González P, Garcia-Madrona S, Garcia-Ribas G, Giegling I, Giorgio G, Goldhardt O, González-Pérez A, Grande G, Green E, Guetta-Baranes T, Haapasalo A, Hadjigeorgiou G, Hampel H, Hardy J, Hartmann AM, Leonenko G, Harwood J, Helisalmi S, Heneka MT, Hernández I, Herrmann MJ, Hoffmann P, Holmes C, Vilas RH, Hulsman M, Jan Biessels G, Johansson C, Kilander L, Ståhlbom AK, Kivipelto M, Koivisto A, Kornhuber J, Kosmidis MH, Lage C, Laukka EJ, Lauria A, Lehtisalo J, Lerch O, Lleó A, de Munain AL, Love S, Löwemark M, Luckcuck L, Macías J, MacLeod CA, Maier W, Mangialasche F, Marco S, Marquié M, Marshall R, Montes AM, Rodríguez CM, Mead S, Medina M, Meggy A, Mendoza S, Menéndez-González M, Mol M, Montrreal L, Morgan K, Nöthen MM, Ngandu T, Nordestgaard BG, Olaso R, Orellana A, Orsini M, Capdevila M, Padovani A, Paolo C, Martinez-Lucas M, Pericard P, Pineda JA, Pisanu C, Polak T, Posthuma D, Priller J, Puerta R, Quenez O, Quintela I, Rábano A, Reinders MJT, Riederer P, Olivé C, Rongve A, Allende IR, Rosende-Roca M, Royo JL, Rubino E, Sáez ME, Sakka P, Saltvedt I, García-Gutierrez F, Sánchez-Arjona MB, Sanchez-Garcia F, Sánchez-Juan P, Sánchez-Valle R, Sando SB, Scamosci M, Scarpini E, Scherer M, Schmid M, Schott JM, Selbæk G (2025) Machine learning in Alzheimer’s disease genetics. Nat Commun 16(1):6726. https://doi.org/10.1038/s41467-025-61650-z
Google Scholar
Brinkmann V, Billich A, Baumruker T, Heining P, Schmouder R, Francis G, Aradhye S, Burtin P (2010) Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat Rev Drug Discov 9(11):883–897. https://doi.org/10.1038/nrd3248
Google Scholar
Briquet M, Rocher AB, Alessandri M, Rosenberg N, de Castro Abrantes H, Wellbourne-Wood J, Schmuziger C, Ginet V, Puyal J, Pralong E, Daniel RT, Offermanns S, Chatton JY (2022) Activation of lactate receptor HCAR1 down-modulates neuronal activity in rodent and human brain tissue. J Cereb Blood Flow Metab 42(9):1650–1665. https://doi.org/10.1177/0271678x221080324
Google Scholar
Butler PM, Yang J, Brown R, Hobbs M, Becker A, Penalver-Andres J, Syz P, Muller S, Cosne G, Juraver A, Song HH, Saha-Chaudhuri P, Roggen D, Scotland A, Silveira N, Demircioglu G, Gabelle A, Hughes R, Erkkinen MG, Langbaum JB, Lingler JH, Price P, Quiroz YT, Sha SJ, Sliwinski M, Porsteinsson AP, Au R, Bianchi MT, Lenyoun H, Pham H, Patel M, Belachew S (2025) Smartwatch- and smartphone-based remote assessment of brain health and detection of mild cognitive impairment. Nat Med 31(3):829–839. https://doi.org/10.1038/s41591-024-03475-9
Google Scholar
Chasseigneaux S, Cochois-Guégan V, Lecorgne L, Lochus M, Nicolic S, Blugeon C, Jourdren L, Gomez-Zepeda D, Tenzer S, Sanquer S, Nivet-Antoine V, Menet MC, Laplanche JL, Declèves X, Cisternino S, Saubaméa B (2024) Fasting upregulates the monocarboxylate transporter MCT1 at the rat blood-brain barrier through PPAR δ activation. Fluids Barriers CNS 21(1):33. https://doi.org/10.1186/s12987-024-00526-8
Google Scholar
Cheng J, Zhao H (2024) NEK7 induces lactylation in Alzheimer’s disease to promote pyroptosis in BV-2 cells. Mol Brain 17(1):81. https://doi.org/10.1186/s13041-024-01156-9
Google Scholar
Cho S, Yang P-S, Kim D, You SC, Sung J-H, Jang E, Yu HT, Kim T-H, Pak H-N, Lee M-H, Joung B (2022) Association of cardiovascular health with the risk of dementia in older adults. Sci Rep 12(1):15673. https://doi.org/10.1038/s41598-022-20072-3
Google Scholar
Cholerton B, Baker LD, Montine TJ, Craft S (2016) Type 2 diabetes, cognition, and dementia in older adults: toward a precision health approach. Diabetes Spectr 29(4):210–219. https://doi.org/10.2337/ds16-0041
Google Scholar
Coll RC, Robertson AAB, Chae JJ, Higgins SC, Muñoz-Planillo R, Inserra MC, Vetter I, Dungan LS, Monks BG, Stutz A, Croker DE, Butler MS, Haneklaus M, Sutton CE, Núñez G, Latz E, Kastner DL, Mills KHG, Masters SL, Schroder K, Cooper MA, O’Neill LAJ (2015) A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med 21(3):248–255. https://doi.org/10.1038/nm.3806
Google Scholar
Coughlin JM, Du Y, Lesniak WG, Harrington CK, Brosnan MK, O’Toole R, Zandi A, Sweeney SE, Abdallah R, Wu Y, Holt DP, Hall AW, Dannals RF, Solnes L, Horti AG, Pomper MG (2022a) First-in-human use of (11)C-CPPC with positron emission tomography for imaging the macrophage colony-stimulating factor 1 receptor. EJNMMI Res 12(1):64. https://doi.org/10.1186/s13550-022-00929-4
Google Scholar
Coughlin JM, Du Y, Lesniak WG, Harrington CK, Brosnan MK, O’Toole R, Zandi A, Sweeney SE, Abdallah R, Wu Y, Holt DP, Hall AW, Dannals RF, Solnes L, Horti AG, Pomper MG (2022b) First-in-human use of 11C-CPPC with positron emission tomography for imaging the macrophage colony-stimulating factor 1 receptor. EJNMMI Res 12(1):64. https://doi.org/10.1186/s13550-022-00929-4
Google Scholar
Cummings J, Zhou Y, Lee G, Zhong K, Fonseca J, Cheng F (2023) Alzheimer’s disease drug development pipeline: 2023. Alzheimer’s & Dementia: Translational Research & Clinical Interventions 9(2):e12385. https://doi.org/10.1002/trc2.12385
Google Scholar
Cummings JL, Atri A, Feldman HH, Hansson O, Sano M, Knop FK, Johannsen P, León T, Scheltens P (2025a) Evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer’s disease. Alzheimers Res Ther 17(1):14. https://doi.org/10.1186/s13195-024-01666-7
Google Scholar
Cummings JL, Atri A, Feldman HH, Hansson O, Sano M, Knop FK, Johannsen P, León T, Scheltens P (2025b) Evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer’s disease. Alzheimers Res Ther 17(1):14. https://doi.org/10.1186/s13195-024-01666-7
Google Scholar
Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65(1):1–105. https://doi.org/10.1016/s0301-0082(00)00067-8
Google Scholar
De Nardo D, Latz E (2011) NLRP3 inflammasomes link inflammation and metabolic disease. Trends Immunol 32(8):373–379. https://doi.org/10.1016/j.it.2011.05.004
Google Scholar
DiBona VL, Shah MK, Krause KJ, Zhu W, Voglewede MM, Smith DM, Crockett DP, Zhang H (2021) Metformin reduces neuroinflammation and improves cognitive functions after traumatic brain injury. Neurosci Res 172:99–109. https://doi.org/10.1016/j.neures.2021.05.007
Google Scholar
Divecha YA, Rampes S, Tromp S, Boyanova ST, Fleckney A, Fidanboylu M, Thomas SA (2025) The microcirculation, the blood-brain barrier, and the neurovascular unit in health and Alzheimer disease: The aberrant pericyte is a central player. Pharmacol Rev 77(3):100052. https://doi.org/10.1016/j.pharmr.2025.100052
Google Scholar
van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, Kanekiyo M, Li D, Reyderman L, Cohen S, Froelich L, Katayama S, Sabbagh M, Vellas B, Watson D, Dhadda S, Irizarry M, Kramer LD, Iwatsubo T (2023) Lecanemab in early alzheimer’s disease. N Engl J Med 388(1):9–21. https://doi.org/10.1056/NEJMoa2212948
Google Scholar
Fan AP, An H, Moradi F, Rosenberg J, Ishii Y, Nariai T, Okazawa H, Zaharchuk G (2020) Quantification of brain oxygen extraction and metabolism with [(15)O]-gas PET: a technical review in the era of PET/MRI. Neuroimage 220:117136. https://doi.org/10.1016/j.neuroimage.2020.117136
Google Scholar
Feng L, Gao L (2024) The role of neurovascular coupling dysfunction in cognitive decline of diabetes patients. Front Neurosci 18:1375908. https://doi.org/10.3389/fnins.2024.1375908
Google Scholar
Ferreira LSS, Fernandes CS, Vieira MNN, De Felice FG (2018) Insulin resistance in Alzheimer’s disease. Front Neurosci 12:830. https://doi.org/10.3389/fnins.2018.00830
Google Scholar
Fisslthaler B, Fleming I (2009) Activation and signaling by the AMP-activated protein kinase in endothelial cells. Circ Res 105(2):114–127. https://doi.org/10.1161/circresaha.109.201590
Comments (0)